Clinical strategies / Bruce Chabner -- Preclinical aspects of cancer drug discovery / Ed Sausville ... [et al.] -- Pharmacokinetics / Jerry Collins -- Infertility / Angela Bradbury, Richard Schilsky -- Carcinogenesis / Larry Blaszkowsky -- Antifolates / Carmen Allegra, Brian Monahan -- 5 fluoropyrimidine / Jean Grem -- Cytidine analogues / David Ryan -- Purine analogues / Kenneth Hande -- Hydroxyurea / Bruce Chabner -- Antimicrotuble agents / Eric Rowinsky -- Alkylating agents/clinical & high dose / Roy Jones, Ken Tew -- Nonclassical agents / Henry Friedman -- Platinum analogues / Ed Reed -- Bleomycin / Bruce Chabner -- Antibiotics / Kees Nooter, Jaap Verweij, Edwin Willems -- Topo I: inhibitors / Alex Sparreboom, William Zamboni -- Topo II: anthracyclines / Jim Doroshow -- Topo II: epipodophylotoxins / Yves Pommier, Francios Goldwasser -- L-asparaginase / Bruce Chabner -- Pharmacology of CNS agents / Jeff Supko -- FDA approval / Thomas Roberts -- Catheter and complications / David Kuter, Rachel Rosovsky -- Pharmacogenetics / Robert Diasio, Jeanne Fourie -- New agents / Louise Grochow -- Bisphosphonates / Matthew Smith -- Thalidomide / Paul Richardson -- Inhibitors of tumor angiogenesis / William Gradishar, Anaadriana Zakarija -- Proteosome inhibitors / Owen O'Connor -- Molecular targeted drugs-growth factor receptor inhibitors / Jeff Clark -- Monoclonal antibody therapies / David Scheinberg -- Interferon / Danield Linder, Earnest Borden -- Adoptive therapies / Carl June -- Vaccines / Glenn Dranoff -- Hematopoietic growth factors / William Petros -- Interleukins / Gheath Alatrash ... [et al.] -- Hormonal therapy for breast cancer and prostate / Peter Lebowitz, Sandra Swain, Steven Balk.